We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




MRC Technology Collaborates with RDL on Infectious Disease Diagnostics

By LabMedica International staff writers
Posted on 15 Oct 2013
Print article
The technology transfer organization, MRC Technology Ltd (London, United Kingdom) has entered into collaboration with RDL, (Glasgow, United Kingdom), developer of the RenDx multiplex assay system, to identify and design novel clinical diagnostic tests for infectious disease.

Rupert Jones, RDL’s general manager said, “RDL is delighted to be working with MRC Technology as a leader in translating basic research into commercial opportunities. MRC Technology's expertise and experience will allow us to accelerate development of our assay portfolio, enhancing the capabilities of the RenDx platform and providing end users with additional value and flexibility.”

Mike Dalrymple, MRC Technology added, “MRC Technology will build a capability in early stage translation of diagnostic opportunities from academia at our laboratory facilities in Edinburgh.”

The RenDx Multiplex Assay System provides a new approach to multiplex DNA detection. Starting from the user's existing extraction and amplification methods, the assay utilizes purpose-designed instrumentation to automate the processing and detection of up to nine targets in a single sample. The RenDx multiplex assay system is based on surface enhanced resonance Raman scattering, providing automated, multiplex, high sensitivity, in vitro screening for clinical research.

MRC Technology is an independent life science technology transfer charity, offering professional services to organizations within the academic, charity, biotechnology, and pharmaceutical sectors globally. Its goal is to ensure that innovative life science research reaches its full potential. The company provides technology transfer services, identifying and protecting research, and partnering it with industry to continue development to market. Services include IP management, research, and development for diagnostics, small molecules, and therapeutic antibodies.

Renishaw Diagnostics Ltd is a subsidiary of the Renishaw Group, a global supplier of engineering technologies, medical devices, and Raman spectroscopy systems. Renishaw's products are used in diverse applications such as machine tool automation, additive manufacturing, and medical technologies.

Related Links:
MRC Technology Ltd
RDL

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Liquid Based Cytology Production Machine
LBP-4032
New
Human Insulin CLIA
Human Insulin CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.